SNN

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Smith & Nephew plc

CEO
Roland Diggelmann
Employees
18581
Headquarters

Hatters Lane
Watford, Hertfordshire WD18 8YE
Phone: 4401923477100
http://www.smith-nephew.com/

News

Smith & Nephew UK Ltd: Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting
Feb 12, 2024 20:10pm

Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024. With a first opportunity to see a forthcoming new feature*…


Source:Finanz Nachrichten
Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting
Feb 12, 2024 20:00pm

Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024. With a first opportunity to see a forthcoming new feature* for its CORI ◊ Surgical System, this exclusive image-agnostic* robotic-assisted surgical solution is designed to further help personalize surgery, advance efficiencies, and optimize performance across Smith+Nephew’s orthopaedic reconstruction portfolio.


Source:GlobeNewswire
Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting | SNN Stock News
Feb 12, 2024 20:00pm

Smith+Nephew unveils a glimpse into the future with its CORI Surgical System at AAOS 2024, showcasing a new feature to personalize surgery and enhance performance. The system offers robotic-assisted solutions for knee and hip arthroplasty, improving outcomes and cost-effectiveness. Personalized planning software powered by AI further enhances patient satisfaction and clinical outcomes.


Source:Stock Titan
Smith & Nephew UK Ltd: Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting
Feb 12, 2024 13:10pm

12 February 2024 Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the premiere of its newly acquired CARTIHEAL? AGILI-C? Cartilage Repair Implant alongside the REGE…


Source:Finanz Nachrichten
Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting | SNN Stock News
Feb 12, 2024 13:00pm

Smith+Nephew introduces CARTIHEAL AGILI-C Cartilage Repair Implant and REGENETEN Bioinductive Implant at AAOS Annual Meeting, revolutionizing soft tissue repair in Sports Medicine with proven clinical evidence.


Source:Stock Titan
Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report
Jan 14, 2024 21:00pm

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a new report examining musculoskeletal injury care and reimbursement in Australia that urges health payers and providers to resolve system-wide challenges hindering positive patient pathways from primary settings through to recovery. The Economist Impact - Musculoskeletal Injuries in Australia Report outlines


Source:Wallstreet:Online
Smith & Nephew UK Ltd: New study confirms Smith+Nephew''s REGENETEN Bioinductive Implant reduces full-thickness rotator cuff re-tear rates by 68%
Jan 11, 2024 12:10pm

First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears Smith+Nephew, the report concluded that at one-year, medium and large …


Source:Finanz Nachrichten
New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%
Jan 11, 2024 12:00pm

First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears


Source:GlobeNewswire
New study confirms Smith+Nephew’s REGENETEN Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%
Jan 11, 2024 12:00pm

First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces standout results for its REGENETEN Bioinductive Implant from a recently completed randomized controlled trial (RCT). Published


Source:Wallstreet:Online
Three Quick Facts: Persimmon, Sainsbury, Smith & Nephew
Jan 10, 2024 07:30am

Tony Cross picks three things to know about the markets, featuring Persimmon, Sainsbury, Smith & Nephew


Source:The Armchair Trader